Home > Financial Ratios > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SMS PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

SMS PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 103.90-50.38-3.8346.34-8.99

What is the latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS is 103.90 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024103.90
Mar2023-50.38
Mar2022-3.83
Mar202146.34
Mar2020-8.99

How is Core EBITDA Growth of SMS PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 103.9
Positive
Mar2023 -50.38
Negative
Mar2022 -3.83
Negative
Mar2021 46.34
Positive
Mar2020 -8.99 -

Other Financial Ratios of SMS PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SMS PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS ₹1,571.6 Cr -12.7% -14.7% 29.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,259.0 Cr 0.5% -3.4% 13.4% Stock Analytics
DIVIS LABORATORIES ₹154,917.0 Cr -2.2% 0.3% 58.8% Stock Analytics
CIPLA ₹119,705.0 Cr 2.2% 3.9% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,953.9 Cr -1.5% -7% -5% Stock Analytics
ZYDUS LIFESCIENCES ₹91,889.3 Cr -2.3% -7.4% 3.7% Stock Analytics


SMS PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

-12.7%

-14.7%

29.5%

SENSEX

-0.4%

-1.4%

5.4%


You may also like the below Video Courses